Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Interferon alpha induces a good molecular response in a patient with chronic eosinophilic leukemia (CEL) carrying the JAK2V617F point mutation.

Helbig G, Stella-Holowiecka B, Majewski M, Lewandowska M, Holowiecki J.

Haematologica. 2007 Nov;92(11):e118-9.

PMID:
18024388
[PubMed - indexed for MEDLINE]
Free Article
2.

[The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].

Chrobák L, Voglová J.

Vnitr Lek. 2005 Dec;51(12):1385-93. Review. Czech.

PMID:
16430106
[PubMed - indexed for MEDLINE]
3.

Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: clinical implications.

Panani AD.

Cancer Lett. 2009 Oct 18;284(1):7-14. doi: 10.1016/j.canlet.2009.02.010. Epub 2009 Mar 9. Review.

PMID:
19269737
[PubMed - indexed for MEDLINE]
4.

Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon.

Butterfield JH.

Immunol Allergy Clin North Am. 2007 Aug;27(3):493-518. Review.

PMID:
17868861
[PubMed - indexed for MEDLINE]
5.

[Restrictive cardiomyopathy with eosinophilic leukemia].

Ohta M, Abe A, Kaguchi Y, Sato S.

Ryoikibetsu Shokogun Shirizu. 1996;(14):88-93. Review. Japanese. No abstract available.

PMID:
9047804
[PubMed - indexed for MEDLINE]
6.

Eosinophilic leukaemia.

Fletcher S, Bain B.

Br Med Bull. 2007;81-82:115-27. Epub 2007 Apr 18. Review.

PMID:
17442690
[PubMed - indexed for MEDLINE]
7.

[Primary hypereosinophilic syndrome].

Ballanger F, Barbarot S, Hamidou M.

Ann Dermatol Venereol. 2006 May;133(5 Pt 1):487-94. Review. French. No abstract available.

PMID:
16760844
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk